Anhedonia cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{CMG}} ; {{AE}} {{PB}} ==Overview== ==Cost-Effectiveness of Therapy== ==References== {{Reflist|2}} Category:Psychiatry Category:Neurology Category:Up-...") |
No edit summary |
||
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
Anhedonia seems to be an important factor influencing prognosis of many diseases. Few studies have shown reduced outcome in the presence of anhedonia. | |||
==Cost-Effectiveness of Therapy== | ==Cost-Effectiveness of Therapy== | ||
==References== | ==References== | ||
Revision as of 13:07, 24 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]
Overview
Anhedonia seems to be an important factor influencing prognosis of many diseases. Few studies have shown reduced outcome in the presence of anhedonia.